Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia

https://doi.org/10.1016/j.schres.2014.09.006Get rights and content

Abstract

Individuals with schizophrenia often show substantial deficits in social cognitive abilities, which are strongly associated with social functioning. To advance our understanding of the genetic variation that is associated with social cognitive deficits in schizophrenia, we genotyped 74 schizophrenia outpatients who completed social cognitive performance measures assessing mentalizing, social perception, and emotional intelligence, as well as clinical symptoms. We assessed seven single nucleotide polymorphisms (SNPs) of the oxytocin receptor (OXTR) previously found to show replicable associations with socio-emotional processes. For one of the seven SNPs, rs2268493, the ‘T’ allele was significantly associated with poorer performance on a composite social cognition index, as well as specific tests of mentalizing and social perception. None of the SNPs were associated with clinical symptoms. Though the sample size is small, these findings provide initial support for the involvement of genetic variants of the OXTR in social cognitive impairments in schizophrenia.

Introduction

Individuals with schizophrenia often show marked deficits in social cognitive abilities, and these deficits are predictive of poor functioning (Fett et al., 2011, Horan et al., 2012). However, the mechanisms underlying impaired social cognition and its variability across patients are largely unknown. One possible contributor is the oxytocin system, which plays an important role in social cognition and behaviors in humans and other animals (Meyer-Lindenberg et al., 2011). This system is of particular interest in schizophrenia, given several recent studies suggesting potential use of intranasal oxytocin as a therapeutic agent (MacDonald and Feifel, 2012).

Many genetic studies have investigated the role of the oxytocin system in social processes, primarily in healthy individuals, and most have focused on genetic variation of the oxytocin receptor (OXTR) (Ebstein et al., 2012). The two most widely studied single nucleotide polymorphisms (SNPs) of the OXTR are rs53576 and rs2254298. These SNPs have frequently shown associations with empathy and various pro-social behaviors, though not all studies have supported such links (Bakermans-Kranenburg and van Ijzendoorn, 2014). Other OXTR SNPs have also shown replicable associations with similar pro-social behaviors (Kumsta and Heinrichs, 2013).

In schizophrenia research, several OXTR SNPs have shown initial associations with the schizophrenia diagnosis in case–control studies (Souza et al., 2010b, Watanabe et al., 2012, Montag et al., 2013b), as well as with symptom severity and response to clozapine therapy (Souza et al., 2010a, Montag et al., 2012, Montag et al., 2013b). Very little is known about the relationship of OXTR in schizophrenia and social cognition. Only one previous report examined this connection and used a self-report measure of empathy. That study found schizophrenia patients with an ‘A’ allele of rs2254298 scored higher on one subscale (i.e., Empathic Concern) than those with the ‘GG’ genotype (Montag et al., 2012).

Given the potential importance of genetic variation in the OXTR and the limited knowledge of its role in schizophrenia, we genotyped seven OXTR SNPs in schizophrenia patients who had been characterized on social cognitive performance measures. The seven SNPs were chosen based on their replicated associations with socio-emotional processing variables in prior studies. Considering the relatively small sample size, we view these findings as hypothesis-generating for future larger studies.

Section snippets

Participants

Participants were a subset of a larger study on social cognitive determinants of outcome (Green et al., 2012) and consisted of 74 schizophrenia outpatients (Table 1) recruited from the VA Greater Los Angeles Healthcare System (VAGLAHS) and the surrounding community. Selection criteria included age 18–60, black or white race, no active substance use disorder within the prior 6 months, no neurological disorders, IQ > 70 based on medical record review, no prior loss of consciousness > 1 h, fluency in

Social cognitive performance

Of the 7 genotyped SNPs, only one showed statistically significant (p < .05) differences among allele subgroups on the social cognitive measures (Table 3). Rs2268493 genotypes showed significant differences on the social cognition summary score, as well as the TASIT and PONS. The differences involving this SNP (using z-scores of individual social cognitive measures) are shown in Fig. 1. Participants with the ‘TT’ genotype (n = 50), the identified risk allele (Kawamura et al., 2010, Campbell et al.,

Discussion

These findings provide preliminary support for the involvement of genetic variants of the OXTR in social cognitive impairments in schizophrenia. Of the 7 SNPs examined, one of these, rs2268493, showed a significant association with social cognitive performance in this sample of schizophrenia individuals. Our finding that the “T” allele of this SNP was associated with poorer social cognition, particularly in the areas of mentalizing and social perception, is consistent with prior studies in

Role of funding source

This work was supported by NIH MH043292 to MFG; NIH MH094613-01 to ELN; and the VA Desert Pacific Mental Illness Research, Education, and Clinical Center.

Contributors

All authors contributed significantly and collaboratively to this work. Dr. Davis, Dr. Horan, Dr. Nurmi, and Dr. Green designed this study. Dr. Horan and Dr. Green developed the social cognitive assessment battery and interpreted the social cognitive data. Dr. Nurmi and Ms. Li performed genetic analyses and helped interpret genetic data. Dr. Rizzo and Dr. Sugar performed statistical analyses and provided support for data analysis. Dr. Davis wrote the first draft of the manuscript. All authors

Conflicts of interest

Dr. Green reports having been a consultant to AbbVie, Dainippon Sumitomo Pharma, Forum, and Roche; he is a member of the scientific board for Mnemosyne; and he has received research funds from Amgen.

None of the authors of this manuscript have conflicts of interest to disclose.

Acknowledgments

We thank Mark McGee for study coordination and all of the individuals who participated in this study.

References (55)

  • J. Park et al.

    Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD

    Prog. Neuro-Psychopharmacol. Biol. Psychiatry

    (2010)
  • H.E. Ross et al.

    Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior

    Front. Neuroendocrinol.

    (2009)
  • R.P. Souza et al.

    Variants in the oxytocin gene and risk for schizophrenia

    Schizophr. Res.

    (2010)
  • R.J. Thompson et al.

    Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls

    Psychoneuroendocrinology

    (2011)
  • H. Walum et al.

    Variation in the oxytocin receptor gene is associated with pair-bonding and social behavior

    Biol. Psychiatry

    (2012)
  • N. Wu et al.

    The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy

    J. Affect. Disord.

    (2012)
  • S. Wu et al.

    Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population

    Biol. Psychiatry

    (2005)
  • N.C. Andreasen

    The Scale for the Assessment of Negative Symptoms (SANS)

    (1984)
  • M.J. Bakermans-Kranenburg et al.

    Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting

    Soc. Cogn. Affect. Neurosci.

    (2008)
  • M.J. Bakermans-Kranenburg et al.

    A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans

    Psychiatr. Genet.

    (2014)
  • D.B. Campbell et al.

    Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder

    J. Neurodev. Disord.

    (2011)
  • F.S. Chen et al.

    Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans

    Proc. Natl. Acad. Sci.

    (2011)
  • J. Cohen

    Statistical Power Analysis for the Behavioral Sciences

    (1988)
  • 1000 Genomes Project Consortium

    An integrated map of genetic variation from 1,092 human genomes

    Nature

    (2012)
  • C.R. Damiano et al.

    Association between the oxytocin receptor (OXTR) gene and mesolimbic responses to rewards

    Mol. Autism

    (2014)
  • M.F. Green et al.

    From perception to functional outcome in schizophrenia: modeling the role of ability and motivation

    Arch. Gen. Psychiatry

    (2012)
  • W.P. Horan et al.

    Social cognition in schizophrenia, part 2: 12-month stability and prediction of functional outcome in first-episode patients

    Schizophr. Bull.

    (2012)
  • Cited by (33)

    • Relationship between the domains of theory of mind, social dysfunction, and oxytocin in schizophrenia

      2022, Journal of Psychiatric Research
      Citation Excerpt :

      Growing evidence indicates an association between oxytocin receptor gene variants and the specific symptoms of schizophrenia. For example, oxytocin receptor gene variants rs53576 and rs2268493 have been associated with poor performance with ToM (Davis et al., 2014; Nakata et al., 2021). The involvement of neural circuits encompassing the medial prefrontal cortex, right insula, and precuneus (Jáni and Kašpárek, 2018) may indicate another mechanism that explains the modulation of oxytocin in the ToM of patients with schizophrenia.

    • Clinical convergence of autism, schizophrenia, and Alzheimer’s disease: The case of social cognition

      2020, Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease
    • Clinical convergence of autism, schizophrenia, and Alzheimer's disease: The case of social cognition

      2019, Neuroprotection in Autism, Schizophrenia and Alzheimer's disease
    • Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research

      2019, Schizophrenia Research
      Citation Excerpt :

      Evidence supporting a relationship between oxytocin and schizophrenia comes from studies demonstrating that lower levels of oxytocin in the cerebrospinal fluid (CSF) were associated with more severe negative symptoms in patients (Sasayama et al., 2012). Single nucleotide polymorphisms at the oxytocin receptor were significantly associated with worse performance on social cognition and social perception tasks (Davis et al., 2014b). Moreover, a recent review of several clinical studies described an association between oxytocin and negative symptoms of schizophrenia (Shilling and Feifel, 2016).

    View all citing articles on Scopus
    View full text